A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Halothane
Vorinostat
The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Levocetirizine.
Halothane
Pheniramine
The risk or severity of QTc prolongation can be increased when Pheniramine is combined with Levocetirizine.
Halothane
Ajmaline
The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Levocetirizine.
Halothane
Encainide
The risk or severity of QTc prolongation can be increased when Encainide is combined with Levocetirizine.
Halothane
Pitolisant
The therapeutic efficacy of Pitolisant can be decreased when used in combination with Levocetirizine.
Halothane
Delamanid
Levocetirizine may increase the QTc-prolonging activities of Delamanid.
Halothane
Vemurafenib
The risk or severity of QTc prolongation can be increased when Levocetirizine is combined with Vemurafenib.
Halothane
Remimazolam
The risk or severity of adverse effects can be increased when Levocetirizine is combined with Remimazolam.
Halothane
Dimetacrine
The risk or severity of adverse effects can be increased when Levocetirizine is combined with Dimetacrine.
Halothane
Lithium cation
The risk or severity of adverse effects can be increased when Lithium cation is combined with Levocetirizine.
Halothane
Lemborexant
The risk or severity of adverse effects can be increased when Levocetirizine is combined with Lemborexant.
Halothane
Tianeptine
The risk or severity of adverse effects can be increased when Levocetirizine is combined with Tianeptine.
Halothane
Stiripentol
The risk or severity of adverse effects can be increased when Levocetirizine is combined with Stiripentol.
Halothane
Lurasidone
The risk or severity of adverse effects can be increased when Levocetirizine is combined with Lurasidone.
Halothane
Fosphenytoin
The risk or severity of adverse effects can be increased when Fosphenytoin is combined with Levocetirizine.
Halothane
Tropisetron
The risk or severity of adverse effects can be increased when Levocetirizine is combined with Tropisetron.
Halothane
Toloxatone
The risk or severity of adverse effects can be increased when Levocetirizine is combined with Toloxatone.
Halothane
Pirlindole
The risk or severity of adverse effects can be increased when Levocetirizine is combined with Pirlindole.
Halothane
Etoperidone
The risk or severity of adverse effects can be increased when Levocetirizine is combined with Etoperidone.
Halothane
Viloxazine
The risk or severity of adverse effects can be increased when Levocetirizine is combined with Viloxazine.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3